News items related to: News
-
New research highlights the importance of monitoring intellectual property rights in TB vaccine innovation
Frontiers in Public Health recently published research identifying potential challenges to accessing these vaccines. This important research, which increases the...
-
Colombian Civil Society Challenges Merck Patent on Monthly HIV Prevention Pill MK-8527
In its opposition filing in late 2025 with the patent office of Colombia, the Superintendency of Industry and Commerce, Fundación...
-
TNP+ Wins Landmark Patent Opposition against Unlawful HCV Treatment Patent
By successfully challenging an unlawful and potentially evergreening patent application, TNP+ has helped protect competition in the pharmaceutical market and strengthened the prospects for more affordable hepatitis C treatment in Thailand.
-
Kenya Ratifies UAE Trade Deal Threatening Access to Affordable Medicines
Kenya has ratified a trade deal that undermines access to affordable medicines, weakens local production, and is “a direct assault on the constitutional right to health” according to MMA partner KELIN, who together with civil society groups and impacted communities, sought to strike clauses in the agreement which restrict and hinder public health.
-
MMA Partner Celebrates Milestone in Opposing Evergreening of TB Drug Patents in Vietnam
The Intellectual Property Office of Vietnam revoked claims 1-19, 21-23, and 25-32 by J&J, stating that J&J’s argument to patent...
-
Fundación GEP Marks Landmark Wins on Lenacapavir and Cabotegravir for Affordable HIV Prevention and Treatment in Argentina
The filing of oppositions is a fundamental strategic line of the FGEP’s Health Access Program, which allows the prevention and...
-
Activists Demand $40-a-year Generic Price for Breakthrough HIV Prevention Drug be Made Available to all Low- and Middle-Income Countries
A global coalition reacted to two deals announced today to make long acting lenacapavir (LEN-LA), a 6 monthly HIV PrEP...
-
Procurement Non-Transparency, Overreliance on Donors, and Lacking Political Will for Local Production: Recent Africa Market Intelligence Analysis
The reports, published by the Kenya Legal and Ethical Issues Network on HIV and AIDS (KELIN – Kenya), Community Health...
-
ITPC Global Hosts Summit, Marking 30 years of Global Injustice
Organized by ITPC Global and the Make Medicines Affordable consortium, the summit brought together over 100 activists, policymakers, and researchers...
-
Brazil’s ABIA Leads Fight Against Patent Barriers to HIV, TB and Other Life-Saving Medicines
Through its Working Group on Intellectual Property (GTPI), ABIA has filed more than 40 oppositions since 2006 against patents on...
-
New Analysis Exposes Path to Affordable Lenacapavir for HIV Prevention
Lenacapavir, administered just twice a year, has been shown to reduce HIV transmission to nearly zero. However, the drug’s high...
-
Ever-greening Patents – a Common Trick of Big Pharma, and Access to MDR TB Drug in Thailand
Chalermsak Kittitrakul, TNP+’s Project Manager for Access to Medicines, said, “The civil society’s movement on opposing the patent applications for...